Factors | Surgery (N = 38) | No surgery (N = 11) | P value |
---|---|---|---|
Sex | .55 | ||
Male | 24 (63.2%) | 8 (72.7%) | |
Female | 14 (36.8%) | 3 (27.3%) | |
Age (mean, range) | 78 (75–87) | 80 (75–86) | .07 |
BMI (mean, range) | 21.8 (17.5–26.8) | 22.0 (17.4–25.4) | .81 |
Smoking | .06 | ||
Yes | 9 (23.7%) | 5 (55.6%) | |
No | 29 (76.3%) | 4 (44.4%) | |
Alcohol | .46 | ||
Yes | 12 (31.6%) | 4 (44.4%) | |
No | 26 (68.4%) | 5 (55.6%) | |
HTN | 1.00 | ||
Yes | 19 (50%) | 5 (50%) | |
No | 19 (50%) | 5 (50%) | |
DM | .25 | ||
Yes | 19 (50%) | 3 (30%) | |
No | 19 (50%) | 7 (70%) | |
Charlson comorbidity Index | .92 | ||
0 | 16 (42.1%) | 5 (45.5%) | |
1 | 14 (36.8%) | 4 (36.4%) | |
2 | 6 (15.8%) | 1 (9.1%) | |
3 | 2 (5.3%) | 1 (9.1%) | |
ECOG PS | .19 | ||
0 | 9 (23.7%) | 2 (18.2%) | |
1 | 26 (68.4%) | 6 (54.5%) | |
2 | 3 (7.9%) | 2 (18.2%) | |
3 | 0 | 1 (9.1%) | |
Family Hx. of malignancy | .12 | ||
Yes | 7 (18.4%) | 0 | |
No | 31 (81.6%) | 11 (100%) | |
Location of tumor | .85 | ||
Head | 26 (68.4%) | 8 (72.7%) | |
Body & Tail | 12 (31.6%) | 3 (27.3%) | |
Preoperative data (median ± SD) | |||
Hb (g/dL) | 12.5 ± 1.5 | 13.0 ± 2.0 | .46 |
INR | 1.04 ± 0.19 | 1.10 ± 0.12 | .57 |
T. Bil | 0.8 ± 3.3 | 0.7 ± 1.1 | .17 |
Albumin (g/dL) | 4.1 ± 0.4 | 4.1 ± 0.4 | .54 |
CA 19–9 (U/mL) | 175.0 ± 713.8 | 169.2 ± 663.2 | .98 |
TNM Staging | .32 | ||
1 | 3 (7.9%) | 2 (18.2%) | |
2 | 35 (92.1%) | 9 (81.8%) | |
CTx. and/or RTx. | .95 | ||
Yes | 10 (26.3%) | 3 (27.3%) | |
No | 28 (73.7%) | 8 (72.7%) |